Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Triamcinolone Acetonide-Loaded Polymeric Nanocapsules

Phase 2

DDeraya University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Chronic Rhinosinusitis (CRS)Recruiting

Chronic Rhinosinusitis (CRS)Phase 2

Recruiting

Timeline

Expected Milestones

Q2 2027

Phase 2Recruiting

Chronic Rhinosinusitis (CRS)

NCT07714525

Clinical

Trials by Indication[1]

Chronic Rhinosinusitis (CRS)1 trial

Clinical Evaluation of Triamcinolone Acetonide-loaded Nanoparticles For Nasal Postoperative Application

Recruiting·DDeraya University·Phase 2·NCT07714525·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Triamcinolone Acetonide-Loaded Polymeric Nanocapsules. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Triamcinolone Acetonide-Loaded Polymeric Nanocapsules. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Deraya University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: DDeraya University

Related News